{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:01:29Z","timestamp":1790701289641,"version":"4.1.0"},"reference-count":52,"publisher":"IMR Press","issue":"9","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background: Accumulating evidence suggests that neddylation contributes to tumor initiation and progression. Nonetheless, its biological functions and regulatory mechanisms in lung adenocarcinoma (LUAD) remain poorly understood. Methods: Bioinformatics analyses integrated single-cell RNA sequencing (scRNA-seq) datasets from the Gene Expression Omnibus (GEO) with bulk RNA-seq data from The Cancer Genome Atlas (TCGA). The Seurat package was used for scRNA-seq processing, including cell clustering, annotation, cell-cell interaction analysis, and pseudotime trajectory inference. The survival and pROC packages were used for Kaplan\u2013Meier (KM) survival and receiver operating characteristic (ROC) analyses, respectively. Tissue microarray (TMA) and immunohistochemistry (IHC) analyses were performed to validate biomarker expression. Functional assays, including Cell Counting Kit-8 (CCK-8), colony formation, wound healing, and Transwell assays, were conducted in A549 and NCI-H1975 cells with DNAJB1 knockdown. Results: Eight major cell populations were identified at the single-cell level, among which T\/NK cells, particularly CD8+ effector memory T cells (CD8+ Tem), exhibited strong associations with neddylation. T\/NK cells displayed extensive ligand-receptor-mediated interactions with other cell types. A transcription factor (TF)\u2013target regulatory network was constructed, revealing that Surfactant Protein C (SFTPC), Lipopolysaccharide-Induced TNF Factor (LITAF), Serine\/Threonine Kinase 17B (STK17B), Enah\/Vasp-Like Protein (EVL), FYN Proto-Oncogene, Src Family Tyrosine Kinase (FYN), and Lymphocyte-Specific Protein 1 (LSP1) were associated with favorable prognosis, whereas DNAJB1 correlated with poor survival in LUAD patients. Pseudotime trajectories further delineated dynamic differentiation pathways of T\/NK subsets and differential TF target expression across states. IHC analysis showed elevated DNAJB1 expression in tumors compared with adjacent normal tissues. Moreover, silencing DNAJB1 significantly inhibited proliferation, migration, and invasion in A549 and NCI-H1975 cells. Conclusion: This study identifies neddylation-associated cellular phenotypes and clinically relevant biomarkers in LUAD, providing new mechanistic insights and highlighting potential therapeutic targets for LUAD treatment.<\/jats:p>","DOI":"10.31083\/fbl52485","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:21:51Z","timestamp":1790698911000},"source":"Crossref","is-referenced-by-count":0,"title":["Multi-Omics Analysis and Experimental Validation Uncover Neddylation-Associated Biomarkers and Cellular Landscape in Lung Adenocarcinoma"],"prefix":"10.31083","volume":"31","author":[{"given":"Xiaogang","family":"Peng","sequence":"first","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, 230022 Hefei, Anhui, China"},{"name":"Department of Respiratory and Critical Care Medicine, Yichang Central People\u2019s Hospital, 443000 Yichang, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangming","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Yichang Central People\u2019s Hospital, 443000 Yichang, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5977-1836","authenticated-orcid":true,"given":"Gengyun","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, 230022 Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal for Clinicians. 2024; 74: 229\u2013263.","DOI":"10.3322\/caac.21834"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Luo G, Zhang Y, Rumgay H, Morgan E, Langselius O, Vignat J, et al. Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: a population-based study. The Lancet. Respiratory Medicine. 2025; 13: 348\u2013363.","DOI":"10.1016\/S2213-2600(24)00428-4"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nik\u0161i\u0107 M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet (London, England). 2018; 391: 1023\u20131075.","DOI":"10.1016\/S0140-6736(17)33326-3"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Murphy C, Pandya T, Swanton C, Solomon BJ. Lung Cancer in Nonsmoking Individuals: A Review. JAMA. 2025; 334: 1836\u20131845.","DOI":"10.1001\/jama.2025.17695"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Heymach JV, Harpole D, Mitsudomi T, Taube JM, Galffy G, Hochmair M, et al. Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer. The New England Journal of Medicine. 2023; 389: 1672\u20131684.","DOI":"10.1056\/NEJMoa2304875"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Spicer JD, Garassino MC, Wakelee H, Liberman M, Kato T, Tsuboi M, et al. Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet (London, England). 2024; 404: 1240\u20131252.","DOI":"10.1016\/S0140-6736(24)01756-2"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Balbi M, Capelli S, Caroli A, Culasso NC, Barba M, Senkeev R, et al. CT-Guided Core Needle Biopsy of Pulmonary Lesions Associated With Cystic Airspaces: A Case-Control Study. AJR. American Journal of Roentgenology. 2024; 223: e2431042.","DOI":"10.2214\/AJR.24.31042"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Baratella E, Cernic S, Minelli P, Furlan G, Crim\u00ec F, Rocco S, et al. Accuracy of CT-Guided Core-Needle Biopsy in Diagnosis of Thoracic Lesions Suspicious for Primitive Malignancy of the Lung: A Five-Year Retrospective Analysis. Tomography (Ann Arbor, Mich.). 2022; 8: 2828\u20132838.","DOI":"10.3390\/tomography8060236"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Fang C, Liu C, Qi R, Ding J, Luo T, Yu F, et al. Integrated Analysis of Single-cell and Bulk-RNA Sequencing Data to Identify Redox-related Genes as Prognostic Biomarkers and Therapeutic Targets of Lung Adenocarcinoma With Osimertinib Resistance. Frontiers in Bioscience (Landmark Edition). 2025; 30: 40454.","DOI":"10.31083\/fbl40454"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Chen F, Ma J, Hu S, Wu C, Chen S, Lin J. Prognostic Cell Death Index for Lung Adenocarcinoma: A Comprehensive Transcriptome-Based Analysis of Twelve Programmed Cell Death Pattern Genes. Frontiers in Bioscience (Landmark Edition). 2024; 29: 135.","DOI":"10.31083\/j.fbl2904135"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Zhang S, Yu Q, Li Z, Zhao Y, Sun Y. Protein neddylation and its role in health and diseases. Signal Transduction and Targeted Therapy. 2024; 9: 85.","DOI":"10.1038\/s41392-024-01800-9"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Enchev RI, Schulman BA, Peter M. Protein neddylation: beyond cullin-RING ligases. Nature Reviews. Molecular Cell Biology. 2015; 16: 30\u201344.","DOI":"10.1038\/nrm3919"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Kamitani T, Kito K, Nguyen HP, Yeh ET. Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein. The Journal of Biological Chemistry. 1997; 272: 28557\u201328562.","DOI":"10.1074\/jbc.272.45.28557"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Jones J, Wu K, Yang Y, Guerrero C, Nillegoda N, Pan ZQ, et al. A targeted proteomic analysis of the ubiquitin-like modifier nedd8 and associated proteins. Journal of Proteome Research. 2008; 7: 1274\u20131287.","DOI":"10.1021\/pr700749v"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Zhou L, Jiang Y, Luo Q, Li L, Jia L. Neddylation: a novel modulator of the tumor microenvironment. Molecular Cancer. 2019; 18: 77.","DOI":"10.1186\/s12943-019-0979-1"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Xie P, Peng Z, Chen Y, Li H, Du M, Tan Y, et al. Neddylation of PTEN regulates its nuclear import and promotes tumor development. Cell Research. 2021; 31: 291\u2013311.","DOI":"10.1038\/s41422-020-00443-z"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Mao H, Lin X, Sun Y. Neddylation Regulation of Immune Responses. Research (Washington, D.C.). 2023; 6: 0283.","DOI":"10.34133\/research.0283"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Zhou L, Zhang W, Sun Y, Jia L. Protein neddylation and its alterations in human cancers for targeted therapy. Cellular Signalling. 2018; 44: 92\u2013102.","DOI":"10.1016\/j.cellsig.2018.01.009"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Zhou L, Jia L. Targeting Protein Neddylation for Cancer Therapy. Advances in Experimental Medicine and Biology. 2020; 1217: 297\u2013315.","DOI":"10.1007\/978-981-15-1025-0_18"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"He ZX, Yang WG, Zengyangzong D, Gao G, Zhang Q, Liu HM, et al. Targeting cullin neddylation for cancer and fibrotic diseases. Theranostics. 2023; 13: 5017\u20135056.","DOI":"10.7150\/thno.78876"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Jiang P, Zhang Y, Ru B, Yang Y, Vu T, Paul R, et al. Systematic investigation of cytokine signaling activity at the tissue and single-cell levels. Nature Methods. 2021; 18: 1181\u20131191.","DOI":"10.1038\/s41592-021-01274-5"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Decker JT, Hall MS, Nanua D, Orbach SM, Roy J, Angadi A, et al. Dynamic Transcriptional Programs During Single NK Cell Killing: Connecting Form to Function in Cellular Immunotherapy. Cellular and Molecular Bioengineering. 2024; 17: 177\u2013188.","DOI":"10.1007\/s12195-024-00812-3"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Zhang Z, Li Y, Wang M, Jing Y, Hu H, Shi M, et al. Identification of differentiation markers and immune microenvironment in head and neck squamous cell carcinoma using machine learning combined with single-cell analysis. Translational Cancer Research. 2025; 14: 8579\u20138599.","DOI":"10.21037\/tcr-2025-1723"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Qiu X, Hill A, Packer J, Lin D, Ma YA, Trapnell C. Single-cell mRNA quantification and differential analysis with Census. Nature Methods. 2017; 14: 309\u2013315.","DOI":"10.1038\/nmeth.4150"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Naik SK, Lam EWF, Parija M, Prakash S, Jiramongkol Y, Adhya AK, et al. NEDDylation negatively regulates ERR\u03b2 expression to promote breast cancer tumorigenesis and progression. Cell Death & Disease. 2020; 11: 703.","DOI":"10.1038\/s41419-020-02838-7"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Powell RT, Rinkenbaugh AL, Guo L, Cai S, Shao J, Zhou X, et al. Targeting neddylation and sumoylation in chemoresistant triple negative breast cancer. NPJ Breast Cancer. 2024; 10: 37.","DOI":"10.1038\/s41523-024-00644-4"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Qin A, Wells L, Malhotra B, Gadgeel S, Schneider BJ, Ramnath N, et al. A Phase II Trial of Pevonedistat and Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer. Clinical Lung Cancer. 2024; 25: 128\u2013134.","DOI":"10.1016\/j.cllc.2023.10.011"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Liu H, Shih YH, Wang WL, Chang WL, Wang YC. UBE1C is upregulated and promotes neddylation of p53 in lung cancer. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology. 2023; 37: e23181.","DOI":"10.1096\/fj.202300629R"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Zhou L, Lin X, Zhang L, Chen S, Chen J, Zhou Z, et al. Neddylation pathway promotes myeloid-derived suppressor cell infiltration via NF-\u03baB-mCXCL5 signaling in lung cancer. International Immunopharmacology. 2022; 113: 109329.","DOI":"10.1016\/j.intimp.2022.109329"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Jiang Y, Liang Y, Li L, Zhou L, Cheng W, Yang X, et al. Targeting neddylation inhibits intravascular survival and extravasation of cancer cells to prevent lung-cancer metastasis. Cell Biology and Toxicology. 2019; 35: 233\u2013245.","DOI":"10.1007\/s10565-019-09472-w"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Cui Y, Chen Z, Pan B, Chen T, Ding H, Li Q, et al. Neddylation pattern indicates tumor microenvironment characterization and predicts prognosis in lung adenocarcinoma. Frontiers in Cell and Developmental Biology. 2022; 10: 979262.","DOI":"10.3389\/fcell.2022.979262"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Turner SJ, Bennett TJ, La Gruta NL. CD8+ T-Cell Memory: The Why, the When, and the How. Cold Spring Harbor Perspectives in Biology. 2021; 13: a038661.","DOI":"10.1101\/cshperspect.a038661"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Han J, Khatwani N, Searles TG, Turk MJ, Angeles CV. Memory CD8+ T cell responses to cancer. Seminars in Immunology. 2020; 49: 101435.","DOI":"10.1016\/j.smim.2020.101435"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Reading JL, G\u00e1lvez-Cancino F, Swanton C, Lladser A, Peggs KS, Quezada SA. The function and dysfunction of memory CD8+ T cells in tumor immunity. Immunological Reviews. 2018; 283: 194\u2013212.","DOI":"10.1111\/imr.12657"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Chuensirikulchai K, Pata S, Laopajon W, Takheaw N, Kotemul K, Jindaphun K, et al. Identification of different functions of CD8+ T cell subpopulations by a novel monoclonal antibody. Immunology. 2024; 173: 321\u2013338.","DOI":"10.1111\/imm.13826"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Reiser J, Banerjee A. Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response. Journal of Immunology Research. 2016; 2016: 8941260.","DOI":"10.1155\/2016\/8941260"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Li J, Wu C, Hu H, Qin G, Wu X, Bai F, et al. Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer. Cancer Cell. 2023; 41: 1152\u20131169.e7.","DOI":"10.1016\/j.ccell.2023.04.011"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Jim\u00e9nez-Lasheras B, Velasco-Beltr\u00e1n P, Egia-Mendikute L, P\u00e9rez-Guti\u00e9rrez L, Lee SY, de Blas A, et al. NEDDylation Regulates CD8+ T-cell Metabolism and Antitumor Immunity. Cancer Immunology Research. 2025; 13: 1004\u20131021.","DOI":"10.1158\/2326-6066.CIR-24-0127"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Ren H, Luan Z, Zhang R, Zhang H, Bian C. A novel approach to explore metabolic diseases: Neddylation. Pharmacological Research. 2024; 210: 107532.","DOI":"10.1016\/j.phrs.2024.107532"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Mitra A, Shevde LA, Samant RS. Multi-faceted role of HSP40 in cancer. Clinical & Experimental Metastasis. 2009; 26: 559\u2013567.","DOI":"10.1007\/s10585-009-9255-x"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Park SY, Choi HK, Seo JS, Yoo JY, Jeong JW, Choi Y, et al. DNAJB1 negatively regulates MIG6 to promote epidermal growth factor receptor signaling. Biochimica et Biophysica Acta. 2015; 1853: 2722\u20132730.","DOI":"10.1016\/j.bbamcr.2015.07.024"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Shirani M, Levin S, Shebl B, Requena D, Finkelstein TM, Johnson DS, et al. Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB1. Cancer Research. 2024; 84: 2626\u20132644.","DOI":"10.1158\/0008-5472.CAN-23-4110"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Bauer J, K\u00f6hler N, Maringer Y, Bucher P, Bilich T, Zwick M, et al. The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma. Nature Communications. 2022; 13: 6401.","DOI":"10.1038\/s41467-022-33746-3"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Zhao B, Yang J, Ran F, Shi Y, Yang L, Duan Y, et al. CircBIRC6 affects prostate cancer progression by regulating miR-574-5p and DNAJB1. Cancer Biology & Therapy. 2024; 25: 2399363.","DOI":"10.1080\/15384047.2024.2399363"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Yin Y, Zhang J, Ma T, Chen D, Lu D. miR-1205\/DNAJB1 reverses docetaxel chemoresistance in human triple negative breast carcinoma cells via regulation of mutp53\/TAp63 signaling. Acta Biochimica et Biophysica Sinica. 2022; 54: 37\u201346.","DOI":"10.3724\/abbs.2021006"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Elias D, Ditzel HJ. Fyn is an important molecule in cancer pathogenesis and drug resistance. Pharmacological Research. 2015; 100: 250\u2013254.","DOI":"10.1016\/j.phrs.2015.08.010"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Peng S, Fu Y. FYN: emerging biological roles and potential therapeutic targets in cancer. Journal of Translational Medicine. 2023; 21: 84.","DOI":"10.1186\/s12967-023-03930-0"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Scheuplein F, Renner F, Campbell JE, Campbell R, De Savi C, Eckmann J, et al. Evaluation of STK17B as a cancer immunotherapy target utilizing highly potent and selective small molecule inhibitors. Frontiers in Immunology. 2024; 15: 1411395.","DOI":"10.3389\/fimmu.2024.1411395"},{"key":"ref49","unstructured":"Zhu P, Gu J, Luo Y, Xi Y. Leukocyte-specific protein 1 (LSP1): A key regulator of cytoskeletal dynamics and leukocyte function. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology. 2025; 41: 750\u2013755. (In Chinese)"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Xu D, Zhou X, Min S, Zhang Y, Zhu X, Qiao K, et al. Leukocyte-specific protein 1 is associated with the stage and tumor immune infiltration of cervical cancer. Scientific Reports. 2025; 15: 7566.","DOI":"10.1038\/s41598-025-91066-0"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Waldman MM, Rahkola JT, Sigler AL, Chung JW, Willett BAS, Kedl RM, et al. Ena\/VASP Protein-Mediated Actin Polymerization Contributes to Na\u00efve CD8+ T Cell Activation and Expansion by Promoting T Cell-APC Interactions In Vivo. Frontiers in Immunology. 2022; 13: 856977.","DOI":"10.3389\/fimmu.2022.856977"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Nureki SI, Tomer Y, Venosa A, Katzen J, Russo SJ, Jamil S, et al. Expression of mutant Sftpc in murine alveolar epithelia drives spontaneous lung fibrosis. The Journal of Clinical Investigation. 2018; 128: 4008\u20134024.","DOI":"10.1172\/JCI99287"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/9\/10.31083\/FBL52485","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:22:23Z","timestamp":1790698943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/9\/10.31083\/FBL52485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2768-6701(26)02219-7"],"URL":"https:\/\/doi.org\/10.31083\/fbl52485","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"article-number":"52485"}}